Toronto Stocks Edge Lower; ProMIS Neurosciences Soars on Positive Alzheimer's Treatment Data
By Adriano Marchese
Stocks in Toronto were mildly lower in midday trading Monday as Canada's consumer durables, energy and utilities stocks weighed on indexes. The main gainers of the session were in tech and health tech.
At midday, Canada's S&P/TSX Composite Index were 0.20% lower at 20222.30 while blue-chip S&P/TSX 60 was down 0.25% at 1214.53.
ProMIS Neurosciences shares more than doubled to 8.23 Canadian dollars ($6.23) after the biotechnology company said it presented additional positive preclinical data supporting the potential therapeutic advantage of its lead candidate in treating Alzheimer's disease.
Other market movers:
Shares in Parex Resources were 6.3% lower at C$27.16 after it said it abandoned one of its wells at a Colombia project after testing confirmed there were no economic hydrocarbons at the site.
Lion Electric's Toronto-listed shares jumped in early trading after the company reported raising about $142 million in combined financing. Shares were up 9.7% at C$3.05.
Write to Adriano Marchese at adriano.marchese@wsj.com
(END) Dow Jones Newswires
July 17, 2023 12:16 ET (16:16 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.-
Going Into Earnings, Is Palantir Stock a Buy, a Sell, or Fairly Valued?
-
What’s Happening in the Markets This Week
-
4 Top Dividend-Paying REIT Stock Picks
-
After Earnings, Is Netflix Stock a Buy, a Sell, or Fairly Valued?
-
P-CAPE: A Better Way for Investors to Estimate Future Returns
-
Which Stocks Have Driven the Stealth Large-Value Rally?
-
Forecasts for Q2 GDP Report Show a Healthy but Slowing Economy
-
5 Stocks to Buy as the Market Rally Broadens
-
4 Top US Travel Stock Picks
-
How Do Interest Rates Affect Stock Market Returns?
-
American Airlines Earnings: Ticket Distribution Misstep Affected Results
-
Going Into Earnings, Is Albemarle Stock a Buy, a Sell, or Fairly Valued?
-
3 Top Cybersecurity Stock Picks for Long-Term Investors
-
AbbVie Earnings: Firm Sees Strong Next-Generation Immunology Drugs Sales
-
Ford Earnings: Warranty Problems on Older Vehicles Slam Results
-
ServiceNow Earnings: Operating on a Higher Plane Within Enterprise Software